Sarepta Therapeutics shares soar 50% on positive preliminary results for muscular dystrophy gene therapy
June 19, 2018 at 10:41 AM EDT
Sarepta Therapeutics shares soar 50% on positive preliminary results for muscular dystrophy gene therapy|| 105281719
